Clinical Trials Browser

Phase 2 × Has announcements × Eflornithine × Clear all

NCT02395666 2024-08-06

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Phase 2 Completed

140 enrolled 14 charts 1 FDA

Neuroblastoma